ovid
therapeutics
present
cantor
fitzgerald
virtual
global
healthcare
conference
new
york
globe
newswire
ovid
therapeutics
nasdaq
ovid
biopharmaceutical
company
committed
developing
medicines
transform
lives
people
rare
neurological
diseases
today
announced
management
present
cantor
fitzgerald
virtual
global
healthcare
conference
thursday
september
et
live
audio
webcast
discussion
accessed
events
presentations
section
company
website
archived
replay
webcast
available
company
website
following
live
presentation
ovid
therapeutics
ovid
therapeutics
new
biopharmaceutical
company
using
approach
develop
medicines
transform
lives
patients
rare
neurological
disorders
ovid
broad
pipeline
potential
medicines
company
advanced
investigational
medicine
gaboxadol
currently
clinical
development
treatment
angelman
syndrome
fragile
x
syndrome
ovid
also
developing
soticlestat
collaboration
takeda
pharmaceutical
company
limited
potential
treatment
rare
developmental
epileptic
encephalopathies
dee
information
ovid
please
visit
contacts
investors
media
ovid
therapeutics
investor
relations
public
relations
irpr
investors
steve
klass
burns
mcclellan
sklass
